These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6381832)

  • 1. [Dopaminergic modulation of salt sensitivity in essential hypertension].
    Shikuma R; Kambara S; Yoshimura M; Takashina R; Yamasaki H; Takeda K; Takahashi H; Ijichi H
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):417-23. PubMed ID: 6381832
    [No Abstract]   [Full Text] [Related]  

  • 2. Renin, angiotensin, aldosterone and hormonal regulation of arterial pressure and salt balance. Introductory remarks.
    Laragh JH
    Fed Proc; 1967; 26(1):39-41. PubMed ID: 4289566
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of saline load and metoclopramide on the renal dopaminergic system in patients with heart failure and healthy controls.
    Alvelos M; Ferreira A; Bettencourt P; Pimenta J; Azevedo A; Serrão P; Rocha-Gonçalves F; Soares-da-Silva P
    J Cardiovasc Pharmacol; 2005 Mar; 45(3):197-203. PubMed ID: 15725943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension].
    Gómez-Fernández P; Moreno VG; Cornejo M; Vargas JC; García-Barroso C; Velasco G; Almaraz M
    Nefrologia; 2000; 20(5):415-23. PubMed ID: 11100662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water immersion and salt-sensitivity in essential hypertension.
    Coruzzi P; Musiari L; Mossini GL; Ceriati R; Novarini A
    Scand J Clin Lab Invest; 1993 Oct; 53(6):593-9. PubMed ID: 8266005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic modulation of salt sensitivity in patients with essential hypertension.
    Shikuma R; Yoshimura M; Kambara S; Yamazaki H; Takashina R; Takahashi H; Takeda K; Ijichi H
    Life Sci; 1986 Mar; 38(10):915-21. PubMed ID: 3951317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal endothelin-1 is linked to changes in urinary salt and volume in essential hypertension. Salt Sensitivity Group of the Italian Society of Hypertension.
    Malatino LS; Bellanuova I; Cataliotti A; Cuzzola F; Mallamaci F; Tripepi G; Parlongo S; Cutrupi S; Mangiafico RA; Ferri C; Galletti F; Glorioso N; Strazzullo P; Zoccali C
    J Nephrol; 2000; 13(3):178-84. PubMed ID: 10928293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal correlates of the inadequate natriuretic response to salt loading in idiopathic edema.
    Kuchel O; Buu NT; Racz K; Gutkowska J
    Clin Invest Med; 1987 Mar; 10(2):71-7. PubMed ID: 3555912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of excessive salt-loading on blood pressure, plasma norepinephrine concentration, plasma renin activity, plasma aldosterone concentration and urinary aldosterone excretion in patients with essential hypertension and normotensive subjects].
    Atarashi K
    Nihon Naika Gakkai Zasshi; 1983 Jan; 72(1):38-46. PubMed ID: 6343533
    [No Abstract]   [Full Text] [Related]  

  • 11. The association between salt sensitivity of blood pressure and some polymorphic factors.
    Kojima S; Inenaga T; Matsuoka H; Kuramochi M; Omae T; Nara Y; Yamori Y
    J Hypertens; 1994 Jul; 12(7):797-801. PubMed ID: 7963508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuresis and the renin axis in sodium-sensitive man.
    Luft FC; Weinberger MH; Grim CE; Fineberg NS
    J Hypertens Suppl; 1986 Dec; 4(5):S198-201. PubMed ID: 3553473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of acebutolol on the renin-aldosterone system in essential arterial hypertension].
    Plouin PF; Ménard J; Corvol P
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3234-8. PubMed ID: 1219630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine and nonmodulating hypertension.
    Williams GH; Gordon MS; Stuenkel CA; Conlin PR; Hollenberg NK
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):112S-115S. PubMed ID: 2383375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
    Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
    Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-course of changes in intracellular cations and blood pressure with salt loading in patients with essential hypertension.
    Kainouchi M; Matsuura H; Shingu T; Inoue I; Ishida T; Ozono R; Fujii T; Yuasa A; Oshima T; Kajiyama G
    J Hypertens Suppl; 1991 Dec; 9(6):S302-3. PubMed ID: 1818978
    [No Abstract]   [Full Text] [Related]  

  • 17. Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension.
    Pedersen EB
    Acta Med Scand Suppl; 1980; 636():1-66. PubMed ID: 6103641
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal sodium handling and responsiveness of plasma renin levels in hypertension.
    Jerums G; Doyle AE
    Clin Sci; 1969 Aug; 37(1):79-90. PubMed ID: 5822535
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal abnormalities in nonmodulating essential hypertension.
    Williams GH; Moore TJ; Hollenberg NK
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):39-44. PubMed ID: 3037888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.
    Luchsinger A; Grilli M; Forte P; Morales E; Velasco M
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):509-12. PubMed ID: 8520809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.